Cargando…

Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis

BACKGROUND: The objective of this study was to compare the cost-effectiveness of minimally invasive surgery (MIS) for patients with degenerative lumbar spondylolisthesis (DLS) relative to failed medical management with the cost-effectiveness of hip and knee arthroplasty for matched cohorts of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, Eric J., Ravinsky, Robert A., Coyte, Peter C., Rampersaud, Y. Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Joule Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410474/
https://www.ncbi.nlm.nih.gov/pubmed/34296707
http://dx.doi.org/10.1503/cjs.015719
_version_ 1783747124711653376
author Crawford, Eric J.
Ravinsky, Robert A.
Coyte, Peter C.
Rampersaud, Y. Raja
author_facet Crawford, Eric J.
Ravinsky, Robert A.
Coyte, Peter C.
Rampersaud, Y. Raja
author_sort Crawford, Eric J.
collection PubMed
description BACKGROUND: The objective of this study was to compare the cost-effectiveness of minimally invasive surgery (MIS) for patients with degenerative lumbar spondylolisthesis (DLS) relative to failed medical management with the cost-effectiveness of hip and knee arthroplasty for matched cohorts of patients with osteoarthritis. METHODS: A cohort of patients with DLS undergoing MIS procedures with decompression alone or decompression and instrumented fusion between 2008 and 2014 was matched to cohorts of patients with hip osteoarthritis (OA) and knee OA undergoing total joint replacement. Incremental cost–utility ratios (ICURs) were calculated from the perspective of the Ontario Ministry of Health, using prospectively collected Short Form–6 Dimension utility data. Costs and quality-adjusted life years (QALYs) were discounted at 3% and sensitivity analyses were performed. RESULTS: Sixty-six patients met the inclusion criteria for the DLS cohort (n = 35 for decompression alone), with a minimum follow-up time of 1 year (mean 1.7 yr). The mean age of patients in the DLS cohort was 64.76 years, and 45 patients (68.2%) were female. For each cohort, utility scores improved from baseline to follow-up and the magnitude of the gain did not differ by group. Lifetime ICURs comparing surgical with nonsurgical care were Can$7946/QALY, Can$7104/QALY and Can$5098/QALY for the DLS, knee OA and hip OA cohorts, respectively. Subgroup analysis yielded an increased ICUR for the patients with DLS who underwent decompression and fusion (Can$9870/QALY) compared with that for the patients with DLS who underwent decompression alone (Can$5045/QALY). The rank order of the ICURs by group did not change with deterministic or probabilistic sensitivity analyses. CONCLUSION: Lifetime ICURs for MIS procedures for DLS are similar to those for total joint replacement. Future research should adopt a societal perspective and potentially capture further economic benefits of MIS procedures.
format Online
Article
Text
id pubmed-8410474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher CMA Joule Inc.
record_format MEDLINE/PubMed
spelling pubmed-84104742021-09-03 Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis Crawford, Eric J. Ravinsky, Robert A. Coyte, Peter C. Rampersaud, Y. Raja Can J Surg Research BACKGROUND: The objective of this study was to compare the cost-effectiveness of minimally invasive surgery (MIS) for patients with degenerative lumbar spondylolisthesis (DLS) relative to failed medical management with the cost-effectiveness of hip and knee arthroplasty for matched cohorts of patients with osteoarthritis. METHODS: A cohort of patients with DLS undergoing MIS procedures with decompression alone or decompression and instrumented fusion between 2008 and 2014 was matched to cohorts of patients with hip osteoarthritis (OA) and knee OA undergoing total joint replacement. Incremental cost–utility ratios (ICURs) were calculated from the perspective of the Ontario Ministry of Health, using prospectively collected Short Form–6 Dimension utility data. Costs and quality-adjusted life years (QALYs) were discounted at 3% and sensitivity analyses were performed. RESULTS: Sixty-six patients met the inclusion criteria for the DLS cohort (n = 35 for decompression alone), with a minimum follow-up time of 1 year (mean 1.7 yr). The mean age of patients in the DLS cohort was 64.76 years, and 45 patients (68.2%) were female. For each cohort, utility scores improved from baseline to follow-up and the magnitude of the gain did not differ by group. Lifetime ICURs comparing surgical with nonsurgical care were Can$7946/QALY, Can$7104/QALY and Can$5098/QALY for the DLS, knee OA and hip OA cohorts, respectively. Subgroup analysis yielded an increased ICUR for the patients with DLS who underwent decompression and fusion (Can$9870/QALY) compared with that for the patients with DLS who underwent decompression alone (Can$5045/QALY). The rank order of the ICURs by group did not change with deterministic or probabilistic sensitivity analyses. CONCLUSION: Lifetime ICURs for MIS procedures for DLS are similar to those for total joint replacement. Future research should adopt a societal perspective and potentially capture further economic benefits of MIS procedures. CMA Joule Inc. 2021-07-23 /pmc/articles/PMC8410474/ /pubmed/34296707 http://dx.doi.org/10.1503/cjs.015719 Text en © 2021 CMA Joule Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research
Crawford, Eric J.
Ravinsky, Robert A.
Coyte, Peter C.
Rampersaud, Y. Raja
Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
title Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
title_full Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
title_fullStr Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
title_full_unstemmed Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
title_short Lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
title_sort lifetime incremental cost–utility ratios for minimally invasive surgery for degenerative lumbar spondylolisthesis relative to failed medical management compared with total hip and knee arthroplasty for osteoarthritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410474/
https://www.ncbi.nlm.nih.gov/pubmed/34296707
http://dx.doi.org/10.1503/cjs.015719
work_keys_str_mv AT crawfordericj lifetimeincrementalcostutilityratiosforminimallyinvasivesurgeryfordegenerativelumbarspondylolisthesisrelativetofailedmedicalmanagementcomparedwithtotalhipandkneearthroplastyforosteoarthritis
AT ravinskyroberta lifetimeincrementalcostutilityratiosforminimallyinvasivesurgeryfordegenerativelumbarspondylolisthesisrelativetofailedmedicalmanagementcomparedwithtotalhipandkneearthroplastyforosteoarthritis
AT coytepeterc lifetimeincrementalcostutilityratiosforminimallyinvasivesurgeryfordegenerativelumbarspondylolisthesisrelativetofailedmedicalmanagementcomparedwithtotalhipandkneearthroplastyforosteoarthritis
AT rampersaudyraja lifetimeincrementalcostutilityratiosforminimallyinvasivesurgeryfordegenerativelumbarspondylolisthesisrelativetofailedmedicalmanagementcomparedwithtotalhipandkneearthroplastyforosteoarthritis